Developing treatments for blood cancers and serious blood disorders is important, but it is only part of the equation. We also need to help ensure those who may need our therapies can get them.

Through the Avoidable Blindness Program, Novartis is working with partners to strengthen eye health in sub-Saharan Africa.

We’re honoring World Cancer Day with a new series called “Let’s Talk About the C Word: From Cancer to Cures” to address challenging conversations on cancer.

Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.

Novartis condemns the war in Ukraine and has been providing humanitarian support, financial donations as well as considerable volumes of medicines to those people impacted by the war.

Latest oncology resources and news surrounding Novartis data featured at European Society for Medical Oncology (ESMO)

Novartis is working with partners around the world to help eliminate preventable visual impairment and blindness by reimagining access to eye care.